NCT07336238
Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 9 versions: 8 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 37 words
- Final enrollment: 16 participants (planned 18)
- Secondary endpoints: details revised at 1 of 1 entry
- Site details revised
- Minor Enrollment closed, study ongoing
- Primary completion moved earlier from Jul 1, 2027 to Dec 1, 2026
- Study completion moved earlier from Dec 31, 2027 to May 1, 2027
- Minor Trial status: Recruiting to Active, Not Recruiting
- Site details revised
- Minor Start date changed from estimate of Jun 15, 2026 to May 19, 2026v6
- Notable Start date: May 15, 2026 to Jun 15, 2026v5
Show 2 earlier versionsHide 2 earlier versions
- Notable Start date: Apr 15, 2026 to May 15, 2026
- Eligibility criteria revised
- Secondary endpoints: details revised at 1 of 1 entry
- Study description expanded, about 5 words
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date: Apr 1, 2026 to Apr 15, 2026
- Site details revised
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (1)
Arms and interventions
Patients attend group preparation therapy sessions on days -14 (virtual), -7 (virtual) and -1 (in person), and also attend an individual preparation therapy session on day -1 (in person). Patients receive psilocybin orally (PO) on day 0. Patients may receive an additional "booster" dose 60-90 minutes after the initial dose based on the physician's clinical judgement. Patients attend group integration therapy sessions on days 1 (in person), 8 (virtual), 15 (virtual), and 22 (virtual), and attend individual integration therapy sessions on days 1 (in person) and 8 (virtual).
Behavioral: Psychotherapy
Drugs: Psilocybin
Other: Survey Administration
Sites
1 site in 1 country
- Fred Hutch/University of Washington Cancer ConsortiumSeattle, Washington, United States